Trio Healthcare
Healthcare Technology
Seed Placeholder Loan
2021
www.trioostomycare.com
Trio Healthcare develops, manufactures and distributes a range of innovative silicone-based ostomy care products, designed to provide stoma patients, such as those with ulcerative colitis or Crohn’s disease, with access to products that are gentler to the skin.
Trio is poised to commercialise an innovative new product with clear patient benefits and advantages to disrupt a multi-billion-dollar market. The company has already developed the product, is manufacturing at scale in the UK and is poised for significant growth. The company has very strong leadership with a record of success delivering similar products and exits in similar stage companies.
GMC made a placeholder convertible loan investment into the business as it readies itself to raise a major growth investment round in Autumn 2021.